Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 11:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 1,748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Cardiovascular Diseases, Cardiovascular Risk Factor, Cardiovascular Health
Interventions: Singing with Music Therapist, Singing with Guided Video, Control Arm; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 55 Years to 79 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Kawasaki Disease
Interventions: Defibrotide; Drug
Lead sponsor: New York Medical College; Other
Eligibility: 0 Years to 11 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: New York, New York • Valhalla, New York

Conditions: Cerebral Vasospasm
Interventions: Nautilus NeuroWave, Transcranial Doppler (TCD); Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Ischemia, Cardiac Disease, Risk Factor, Cardiovascular
Interventions: CardioFlux Magnetocardiography; Device
Lead sponsor: Genetesis Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Mason, Ohio

Conditions: Aging, Stress, Disease Risk
Interventions: Aerobic Training Intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 75 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pulmonary Embolism
Interventions: Blood sample; Genetic
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2035
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiovascular Disease
Interventions: Fish Oil and Aspirin; Dietary Supplement
Lead sponsor: University of Rochester; Other
Eligibility: 40 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism, Trauma
Interventions: The Angel® Catheter; Device
Lead sponsor: BiO2 Medical; Industry
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 21
States / cities: Los Angeles, California • San Diego, California • Loveland, Colorado + 18 more

Conditions: Cardiovascular Disease, Obesity
Interventions: Provision of beverages; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 40 Years
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Kidney Disease, Cardiovascular Disease
Interventions: Pomegranate extracts; Dietary Supplement
Lead sponsor: Kenneth Wilund; Other
Eligibility: 30 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Champaign, Illinois

Conditions: Acute Coronary Syndrome
Interventions: PREtest Consult; Device
Lead sponsor: PREtest Consult; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Atherosclerotic Cardiovascular Disease, Hypercholesterolemia
Interventions: Not listed
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 95 participants
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Cardiovascular Diseases, Breast Neoplasms
Interventions: raloxifene, placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 55 Years and older · Female only
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2005
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Peripheral Artery Disease
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Rivaroxaban-Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 50 Years and older
Enrollment: 6,564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 105
States / cities: Alexander City, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 91 more

Conditions: Hypercholesterolemia
Interventions: Controlled Feeding Dietary Intervention; Other
Lead sponsor: USDA Beltsville Human Nutrition Research Center; Federal
Eligibility: 25 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Beltsville, Maryland

Conditions: Cardiovascular Disease, Obesity
Interventions: Maintenance of Weight Loss--Control, Maintenance of Weight Loss--Experimental; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 339 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Kinston, North Carolina

Conditions: Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke, Hypercholesterolemia
Interventions: lerodalcibep, Placebo; Drug · Other
Lead sponsor: LIB Therapeutics LLC; Industry
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Cincinnati, Ohio

Conditions: Coronary Artery Disease
Interventions: IMPLELLA LP 2.5, IABP Intra-aortic balloon pump; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 44
States / cities: Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 35 more

Conditions: Atherosclerosis, Diabetes
Interventions: Mindfulness-based stress reduction, Nutrition Enhancement; Behavioral
Lead sponsor: Montana State University; Other
Eligibility: 25 Years to 55 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Cancer
Interventions: Cardiac Aggressive Risk MitigAtion Plan; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiovascular Disease, Metabolic Syndrome X, Hypercholesterolemia, Inflammation
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 21 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Living Kidney Donation, Hypertension, Nephrectomy
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cardiovascular-kidney-metabolic Syndrome, Cardiovascular Diseases, Hypertension, Diabetes, Hyperlipidemia, Kidney Disease, Obesity, Smoking
Interventions: Inspire HER Intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 30 Years to 79 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Diabetes Mellitus, Type 2, Vascular Diseases
Interventions: Rosiglitazone, Pioglitazone; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 40 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Little Rock, Arkansas

Search by objective public record fields.

Singing and Cardiovascular Health in Older Adults

Defibrotide in Children With High Risk Kawasaki Disease

Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm

Women's Assessed Cardiovascular Evaluation With MCG

Fitness, Cellular Aging, and Caregiver Stress Study

Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty

Fish Oil and Aspirin With Type 2 Diabetes

The Angel® Catheter Pivotal Clinical Trial

Beverages and Societal Health

Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD Patients

Trial for the Use of Pretest Probability to Reduce Unnecessary Testing for Low-Risk Patients With Chest Pain

A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia

Raloxifene Use for The Heart

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

A Comparison of the Effects on Cardiovascular Risk Factors of Korean and American Dietary Profiles

Heart-Healthy Lenoir Lifestyle Study

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction

Protect II, A Prospective, Multicenter Randomized Controlled Trial

Strategies for Inflammation and Cardiovascular Disease (CVD) Prevention

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Inflammatory Profiles of Children at High Risk for Atherosclerosis

Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy

Inspire HER: Inspiring the Heart and Emotions for Radical Health

Effect of Thiazolidinedione Treatment Vascular Risk Markers